Oxford BioMedica (OTCMKTS:OXBDF – Get Free Report)’s share price gapped down prior to trading on Friday . The stock had previously closed at $8.95, but opened at $8.17. Oxford BioMedica shares last traded at $8.17, with a volume of 190 shares changing hands.
Oxford BioMedica Price Performance
The company has a quick ratio of 1.67, a current ratio of 1.89 and a debt-to-equity ratio of 3.08. The stock has a 50 day moving average of $10.55 and a 200 day moving average of $8.92.
Oxford BioMedica Company Profile
Oxford BioMedica is a clinical-stage gene and cell therapy company headquartered in Oxford, United Kingdom. The company specializes in the development, manufacturing and commercialization of lentiviral vector delivery systems for use in treating serious diseases. Its proprietary LentiVector® platform underpins both in-house development programs and third-party collaborations, enabling the stable integration of therapeutic genes into target cells.
In its research pipeline, Oxford BioMedica is advancing candidates across ophthalmology, neuroscience and oncology indications.
See Also
- Five stocks we like better than Oxford BioMedica
- “I just bought 10,000 shares of a $5 stock…”
- 3 Signs You May Want to Switch Financial Advisors
- How JPMorgan’s $8,000 Gold Call Will Leave Most Retirement Accounts Behind
- Silver Is the New Oil—And the World’s Running Dry
- Central banks just did something they haven’t done since 1967
Receive News & Ratings for Oxford BioMedica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford BioMedica and related companies with MarketBeat.com's FREE daily email newsletter.
